Trial Profile
A Post-marketing Clinical Study of Rebamipide to Investigate the Gastric Ulcer Healing Effect of Continued Dosing Following Helicobacter Pylori Eradication Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2023
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Gastric ulcer
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 25 May 2007 Status changed from in progress to completed.
- 05 Nov 2005 New trial record.